Scarica l'app Stockscreener
377.46
1.11%
4.16
Dopo l'orario di chiusura:
375.35
-2.11
-0.56%
Panoramica
Notizia
Cronologia dei prezzi
Catena di opzioni
Financials
Perché SYK Giù?
Forum
Previsione
Frazionamento azionario
Storia dei dividendi
Precedente Chiudi:
$373.30
Aprire:
$369.57
Volume 24 ore:
1.80M
Relative Volume:
1.34
Capitalizzazione di mercato:
$142.48B
Reddito:
$22.60B
Utile/perdita netta:
$2.99B
Rapporto P/E:
48.64
EPS:
7.76
Flusso di cassa netto:
$3.49B
1 W Prestazione:
+2.63%
1M Prestazione:
-2.26%
6M Prestazione:
+6.29%
1 anno Prestazione:
+8.04%
Intervallo 1D:
$366.69
$378.35
Intervallo di 1 settimana:
$361.02
$378.35
Portata 52W:
$314.93
$406.19
Stryker Corp Stock (SYK) Company Profile
Nome
Stryker Corp
Settore
Industria
Telefono
(269) 385-2600
Indirizzo
1941 STRYKER WAY, PORTAGE, MI
Confronta SYK con altri titoli
| Azioni | Prezzo | Cap. di mercato | Reddito | Reddito netto | Flusso di cassa | EPS |
|---|---|---|---|---|---|---|
SYK
Stryker Corp
|
377.46 | 142.48B | 22.60B | 2.99B | 3.49B | 7.76 |
|
ABT
Abbott Laboratories
|
131.93 | 228.81B | 41.95B | 13.40B | 6.35B | 7.65 |
|
BSX
Boston Scientific Corp
|
100.05 | 149.74B | 16.75B | 1.85B | 2.37B | 1.25 |
|
MDT
Medtronic Plc
|
88.86 | 113.49B | 33.20B | 4.26B | 5.47B | 3.29 |
|
EW
Edwards Lifesciences Corp
|
72.05 | 42.10B | 5.72B | 4.17B | 259.90M | 6.97 |
Stryker Corp Stock (SYK) Upgrades & Downgrades
| Data | Azione | Analista | Modifica della valutazione |
|---|---|---|---|
| 2025-02-26 | Ripresa | Citigroup | Buy |
| 2024-12-02 | Aggiornamento | Morgan Stanley | Equal-Weight → Overweight |
| 2024-09-10 | Iniziato | Wolfe Research | Outperform |
| 2024-05-30 | Iniziato | Goldman | Neutral |
| 2024-05-22 | Aggiornamento | Needham | Hold → Buy |
| 2024-01-31 | Aggiornamento | Canaccord Genuity | Hold → Buy |
| 2023-10-20 | Iniziato | ROTH MKM | Buy |
| 2023-09-05 | Aggiornamento | BofA Securities | Neutral → Buy |
| 2023-03-29 | Iniziato | UBS | Neutral |
| 2023-01-25 | Iniziato | KeyBanc Capital Markets | Sector Weight |
| 2023-01-09 | Aggiornamento | RBC Capital Mkts | Sector Perform → Outperform |
| 2022-11-01 | Downgrade | Canaccord Genuity | Buy → Hold |
| 2022-10-18 | Iniziato | Barclays | Overweight |
| 2022-10-12 | Iniziato | Jefferies | Buy |
| 2022-07-28 | Aggiornamento | Edward Jones | Hold → Buy |
| 2022-07-21 | Downgrade | Deutsche Bank | Buy → Hold |
| 2022-07-11 | Downgrade | BofA Securities | Buy → Neutral |
| 2022-04-13 | Iniziato | Truist | Hold |
| 2022-03-16 | Aggiornamento | Bernstein | Mkt Perform → Outperform |
| 2022-03-15 | Ripresa | Evercore ISI | Outperform |
| 2022-03-02 | Ripresa | BofA Securities | Buy |
| 2022-01-07 | Downgrade | Morgan Stanley | Overweight → Equal-Weight |
| 2022-01-04 | Aggiornamento | Piper Sandler | Neutral → Overweight |
| 2021-12-10 | Iniziato | RBC Capital Mkts | Sector Perform |
| 2021-12-07 | Iniziato | Loop Capital | Buy |
| 2021-09-14 | Ripresa | Raymond James | Mkt Perform |
| 2021-07-28 | Aggiornamento | Northland Capital | Market Perform → Outperform |
| 2021-06-01 | Aggiornamento | Evercore ISI | In-line → Outperform |
| 2021-05-25 | Iniziato | Barclays | Underweight |
| 2020-10-06 | Iniziato | Northland Capital | Market Perform |
| 2020-09-11 | Iniziato | Wolfe Research | Peer Perform |
| 2020-04-13 | Downgrade | Barclays | Equal Weight → Underweight |
| 2020-04-01 | Downgrade | Goldman | Buy → Sell |
| 2020-03-05 | Iniziato | Citigroup | Buy |
| 2020-02-13 | Iniziato | Goldman | Buy |
| 2020-01-08 | Iniziato | SunTrust | Hold |
| 2020-01-07 | Downgrade | Piper Jaffray | Overweight → Neutral |
| 2020-01-07 | Downgrade | Piper Sandler | Overweight → Neutral |
| 2019-12-30 | Reiterato | BTIG Research | Buy |
| 2019-11-05 | Downgrade | Barclays | Overweight → Equal Weight |
| 2019-10-30 | Reiterato | BofA/Merrill | Buy |
| 2019-07-02 | Downgrade | Evercore ISI | Outperform → In-line |
| 2019-01-30 | Reiterato | Canaccord Genuity | Buy |
| 2019-01-03 | Iniziato | Deutsche Bank | Buy |
| 2019-01-02 | Aggiornamento | Evercore ISI | In-line → Outperform |
| 2018-10-16 | Iniziato | Barclays | Overweight |
| 2018-08-16 | Iniziato | BTIG Research | Buy |
| 2018-06-27 | Iniziato | Bernstein | Mkt Perform |
| 2018-04-27 | Reiterato | Stifel | Buy |
Mostra tutto
Stryker Corp Borsa (SYK) Ultime notizie
Evercore ISI Adjusts Stryker Price Target to $400 From $410, Maintains Outperform Rating - MarketScreener
Stryker Closes Sale of US Spinal Implants Unit to Vascogliosi Brothers - MarketScreener
Viscogliosi Brothers Completes Acquisition of U.S. Spine Business from Stryker, Creating VB Spine, LLC - Benzinga
Viscogliosi Brothers Completes Acquisition of U.S. Spine Business from Stryker, Creating VB Spine, LLC - Yahoo Finance
Stryker completes sale of U.S. spinal implants business - MarketScreener
Stryker sells US spinal implants business to VB Spine - Investing.com
Stryker Completes Sale Of U.S. Spinal Implants Business - MarketScreener
Major Strategic Shift: Stryker Sells Spinal Unit While Keeping Key Tech Rights - Stock Titan
Stryker : 2024 Comprehensive Report - MarketScreener
Stryker Corporation (NYSE:SYK): One of the Best Robotics Stocks to Buy According to Billionaires - Insider Monkey
Stocks With Rising Relative Strength: Stryker - MSN
California Public Employees Retirement System Raises Stake in Stryker Co. (NYSE:SYK) - MarketBeat
Stryker Corporation (SYK): Jim Cramer Sees Big Gains Despite Tariff Worries - Insider Monkey
Ex-Dividend Reminder: Stryker, Innovative Industrial Properties and Apple Hospitality REIT - Nasdaq
Jim Cramer: Stryker Is A 'Good' Company, Says He Likes This Utilities Stock - Benzinga
Stryker Options Trading: A Deep Dive into Market Sentiment - Benzinga
Stryker increases pay for top execs, reports slightly lower wage for median employee - Medical Design & Outsourcing
Stryker announces intention to nominate Manny Maceda to board of directors - Quantisnow
Stryker nominates new board member - Investing.com
Stryker nominates new board member By Investing.com - Investing.com Canada
Global Transformation Expert and Bain Chairman Joins Stryker's Board - Stock Titan
Is It Smart To Buy Stryker Corporation (NYSE:SYK) Before It Goes Ex-Dividend? - Yahoo Finance
Stryker announces Annual Meeting of Shareholders - Yahoo Finance
Here's How Much $1000 Invested In Stryker 5 Years Ago Would Be Worth Today - Benzinga
Stryker Makes Shareholder Meeting Accessible: Virtual Format Opens Doors to All Investors - Stock Titan
What's Driving the Market Sentiment Around Stryker? - Benzinga
Breaking Down Stryker: 13 Analysts Share Their Views - Benzinga
Needham maintains Stryker stock Buy rating, $442 target - Investing.com
Spinal Fusion Device Market Forecast Report and Company Analysis 2025-2033 Featuring Medtronic, Stryker, Zimmer Biomet, Orthofix Medical, NuVasive, Globus Medical, Xtant Medical, and Alphatec - Yahoo Finance
New Jersey Rep. Thomas Kean Sold Over $17K Worth of Stryker Stock: Here's What You Should Know - Benzinga
Stryker : 2024 Comprehensive Report Factsheet -March 17, 2025 at 08:10 am EDT - Marketscreener.com
Thomas Kean Jr makes notable trades in Amazon, Magnera Corp, and Stryker Corp - Investing.com Australia
Spelman College Receives $30M To Help Fund New Arts Center - Essence
Stryker Unveils Next-Generation Mako SmartRobotics but Stock Falls - MSN
Stryker’s Strong Market Position and Growth Prospects Justify Buy Rating - TipRanks
Stryker Co. (NYSE:SYK) Given Consensus Rating of “Moderate Buy” by Analysts - Defense World
RBC Capital maintains Stryker stock Outperform rating, $435 target - Investing.com
RBC Capital maintains Stryker stock Outperform rating, $435 target By Investing.com - Investing.com South Africa
At US$364, Is It Time To Put Stryker Corporation (NYSE:SYK) On Your Watch List? - Yahoo Finance
Stryker Rides Wave as New Products See Continued Adoption - Morningstar
Piper Sandler maintains $420 target on Stryker stock - Investing.com
Stryker showcases next generation of Mako SmartRobotics™ at AAOS 2025 Annual Meeting - Quantisnow
Revolutionary Upgrade: How Stryker's New Mako Robot Transforms 4 Major Surgeries - StockTitan
Stryker Stock To $300? - Nasdaq
Can SYK Stock Plunge Below $300? - Forbes
Stryker Corp (SYK) Unveils Artix Thrombectomy System for Enhanced Arterial Clot Treatment - GuruFocus.com
Inari Medical, now part of Stryker, launches Artix™ Thrombectomy System, designed to address a broad spectrum of arterial thrombus cases - Marketscreener.com
StockNews.com Downgrades Stryker (NYSE:SYK) to Hold - Defense World
SYK Stock Declines Despite Steri-Shield Launch to Boost OR Portfolio - Yahoo Finance
Is Stryker Stock Outperforming the S&P 500? - Nasdaq
Is Stryker Stock Outperforming The S&P 500? - Barchart
Stryker Corp Azioni (SYK) Dati Finanziari
Reddito
Reddito netto
Flusso di cassa
EPS
1.18%
0.42%
Apri su Yahoo
|
Apri su Google
|
Aperto in Finviz
|
Apri in MarketWatch
|
Aperto a EDGAR
|
Aperto su Reuters
Capitalizzazione:
|
Volume (24 ore):